Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Question & Answer Session on Immunotherapies for Lung Cancer
Author
Howard (Jack) West, MD

Here's the question and answer session that followed the presentations by Drs. Ramaswamy Govindan and Julie Brahmer on the topic of immunotherapies for lung cancer.  Below, you'll find the audio version of the podcast (there really wasn't any real video component for this one), along with the transcript for the program.

[powerpress]

Immunotherapies for LC Q and A Audio Podcast

Immunotherapies for LC Q and A Transcript

We've got a backlog of webinars and podcasts to get out to you, so I'm going to move forward on some more.  

Thanks to LUNGevity Foundation for partnering with us on these programs.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora